article · Pathology - Research and Practice

CBFβ–SMMHC in inv(16) AML: Fusion biology, RUNX1 dysregulation, and therapeutic targeting of a leukemogenic protein–protein interaction

Emadeldin M. Kamel
Sally Mostafa Khadrawy
Faris F. Aba Alkhayl
Mohamed A.M. Ali
Noha A. Ahmed
Saleh Alkhedhairi
Al Mokhtar Lamsabhi

2026Beni Suef University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Acute Myeloid Leukemia Research
Protein Degradation and Inhibitors
Histone Deacetylase Inhibitors Research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.prp.2026.156607

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.